Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01750268Phase 4Completed
Phase 4, randomised, triple-blind trial in alcohol use disorder (AUD) comparing Topiramate with Placebo (2 arms). Primary endpoint: Change in the Number of Drinking Days Per Week at 12 weeks. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01750268.